Guselkumab: the first selective IL-23 inhibitor for active psoriatic arthritis in adults
Journal article

Guselkumab: the first selective IL-23 inhibitor for active psoriatic arthritis in adults

  • 2020-11-28
Published in:
  • Expert Review of Clinical Immunology. - Informa UK Limited. - 2020
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/149518
Statistics

Document views: 31 File downloads: